Followers | 191 |
Posts | 6888 |
Boards Moderated | 0 |
Alias Born | 10/05/2010 |
Monday, May 27, 2019 11:20:32 AM
Share structure: A/S 900m, O/S 500m, Float 383m. Nice numbers here and with an average trading volume over 4m/day it has enough liquidity to accumulate a decent size position without getting trapped in it if the need to exit arises. The recent elimination of convertible notes should stop the slow dilution that has occurred in the last few quarters. Preferred shares potential dilution (all series) amounts to roughly 387m/shares of common; 164m of them belong to KGKG and are unlikely to be converted anytime soon. There are 880k shares of Undesignated Preferred shares which showed up when the Convertible notes were eliminated; there is no conversion rate listed for these and is something worth watching for in the future as the conversion rate on the eliminated notes was quite poor.
The Balance sheet is simply used to determine the fiscal viability of a company. I generally use Cash and Cash Equivalents minus Current Liabilities for short-term solvency, or Total Liabilities for a longer-term picture. VATE has seen steady improvement over the last few quarters; Cash and Receivables currently exceed Total Liabilities which helps to provide confidence in the long-term fiscal viability of the company.
The Income Statement is all about growth. I use three measures of growth; Revenue, Margin and Earnings. When measuring growth rates of company’s that are just coming out of product development or have very small Year over Year Quarter (YoYQ) comparable revenues I prefer to use Sequential quarterly growth rates instead. The last four quarters had sequential revenue growth rates of 18.5%, 6%, 49.7% & 26.4% (most recent). Obviously quite a range of growth rates, but growing none the less, I am using 25% for my future quarterly projections. Gross Margins for the last four quarters were; 75%, 58.1%, 39.3% and 76.1% (most recent), I was pleased to see the gross margins bounce back in the last quarter. I am currently using 65% for my forward projections as I prefer to err on the conservative side. There are currently no earnings for comparison.
If a company is not profitable then the Cash Flow statement can be used to tell us where their money is coming from (selling shares/Conv. Notes etc.). The Cash Flows from Financing Activities section gives us this answer; however, on the Q1 filing this section is not present. I am not concerned w/this due to them only losing $50k for the quarter and at a .04 share price would only equate to 1.25m shares/quarter of required dilution which can easily be absorbed.
The company’s elimination of convertible debt combined with a solid balance sheet and improvement in revenue growth have finally moved VATE into the investable category for me. For fair disclosure, I still hold several hundred thousand dividend shares from its spin off from KGKG.
The profit one makes on an investment or trade is the difference between the entry and exit points, so determining these points of great importance; I use charts to help with my timing and will break them down in another post.
All the best,
Knife
Recent BLEG News
- Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • InvestorsHub NewsWire • 05/30/2024 12:30:00 PM
- Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • InvestorsHub NewsWire • 05/22/2024 12:30:00 PM
- Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • InvestorsHub NewsWire • 05/15/2024 12:30:00 PM
- Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • InvestorsHub NewsWire • 04/16/2024 12:30:00 PM
- Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract • InvestorsHub NewsWire • 04/09/2024 12:30:00 PM
- Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation • InvestorsHub NewsWire • 04/04/2024 12:30:00 PM
- Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc. • InvestorsHub NewsWire • 03/12/2024 01:54:43 PM
- Shares of this Biotech Holdings Company Up on LOI • AllPennyStocks.com • 02/29/2024 06:10:00 PM
- Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC • InvestorsHub NewsWire • 02/29/2024 01:30:00 PM
- Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL • InvestorsHub NewsWire • 02/08/2024 01:30:00 PM
- Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market • InvestorsHub NewsWire • 02/06/2024 02:30:00 PM
- Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00 • InvestorsHub NewsWire • 01/30/2024 02:25:00 PM
- Branded Legacy, Inc. Reduces Debt by 1.5 Million • InvestorsHub NewsWire • 01/25/2024 01:30:00 PM
- Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M • InvestorsHub NewsWire • 01/23/2024 01:30:00 PM
- Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets • InvestorsHub NewsWire • 12/05/2023 01:00:00 PM
- Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • InvestorsHub NewsWire • 11/28/2023 12:23:33 PM
- Branded Legacy Signs Letter of Intent to Acquire $6 Million in Assets and Additional Facility Space • InvestorsHub NewsWire • 11/16/2023 12:00:00 PM
- Branded Legacy, Inc. Announces 1.5B Reduction in Authorized Share Count • InvestorsHub NewsWire • 11/09/2023 12:03:15 PM
- Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements • InvestorsHub NewsWire • 11/07/2023 12:02:43 PM
- Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow • InvestorsHub NewsWire • 10/26/2023 12:30:00 PM
- Rocket Web Development & Design: Navigating the Digital Frontier with Innovation and Excellence • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023 • InvestorsHub NewsWire • 10/19/2023 12:00:00 PM
- Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion • InvestorsHub NewsWire • 10/10/2023 12:25:00 PM
- Total Refinement Solutions LLC Transitions to Royal Biotek Under $BLEG Portfolio • InvestorsHub NewsWire • 10/05/2023 12:18:33 PM
- Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM